Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Erratum to typical asymmetry in the hemispheric activation during an fMRI verbal comprehension paradigm is related to better performance in verbal and non-verbal tasks in patients with epilepsy. NeuroImage: Clinical 20 (2018) 742-752.

Cano-López I, Calvo A, Boget T, Carreño M, Donaire A, Setoain X, Pintor L, Rumià J, González-Bono E, Junqué C, Bargalló N.

Neuroimage Clin. 2019 Feb 4:101700. doi: 10.1016/j.nicl.2019.101700. [Epub ahead of print] No abstract available.

2.

Autoimmune seizures and epilepsy.

Geis C, Planagumà J, Carreño M, Graus F, Dalmau J.

J Clin Invest. 2019 Feb 4. pii: 125178. doi: 10.1172/JCI125178. [Epub ahead of print] Review.

3.

Hippocampus and Insula Are Targets in Epileptic Patients With Glutamic Acid Decarboxylase Antibodies.

Falip M, Rodriguez-Bel L, Castañer S, Sala-Padró J, Miro J, Jaraba S, Casasnovas C, Morandeira F, Berdejo J, Carreño M.

Front Neurol. 2019 Jan 9;9:1143. doi: 10.3389/fneur.2018.01143. eCollection 2018.

4.

Typical asymmetry in the hemispheric activation during an fMRI verbal comprehension paradigm is related to better performance in verbal and non-verbal tasks in patients with epilepsy.

Cano-López I, Calvo A, Boget T, Carreño M, Donaire A, Setoain X, Pintor L, Rumià J, González-Bono E, Junqué C, Bargalló N.

Neuroimage Clin. 2018;20:742-752. doi: 10.1016/j.nicl.2018.09.010. Epub 2018 Sep 15. Erratum in: Neuroimage Clin. 2019 Feb 4;:101700.

5.

PISCOM: a new procedure for epilepsy combining ictal SPECT and interictal PET.

Perissinotti A, Niñerola-Baizán A, Rubí S, Carreño M, Marti-Fuster B, Aparicio J, Mayoral M, Donaire A, Sanchez-Izquierdo N, Bargalló N, Rumiá J, Boget T, Pons F, Lomeña F, Ros D, Pavía J, Setoain X.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2358-2367. doi: 10.1007/s00259-018-4080-6. Epub 2018 Aug 1.

6.

Psychiatric Symptoms in Refractory Epilepsy During the First Year After Surgery.

Ramos-Perdigués S, Baillés E, Mané A, Carreño M, Donaire A, Rumià J, Bargalló N, Boget T, Setoain X, Valdés M, Pintor L.

Neurotherapeutics. 2018 Oct;15(4):1082-1092. doi: 10.1007/s13311-018-0652-1.

PMID:
30066084
7.

Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study.

Villanueva V, Montoya J, Castillo A, Mauri-Llerda JÁ, Giner P, López-González FJ, Piera A, Villanueva-Hernández P, Bertol V, Garcia-Escrivá A, Garcia-Peñas JJ, Garamendi I, Esteve-Belloch P, Baiges-Octavio JJ, Miró J, Falip M, Garcés M, Gómez A, Gil-López FJ, Carreño M, Rodriguez-Uranga JJ, Campos D, Bonet M, Querol R, Molins A, Tortosa D, Salas-Puig J.

Epilepsia. 2018 Sep;59(9):1740-1752. doi: 10.1111/epi.14522. Epub 2018 Jul 31.

PMID:
30062784
8.

Unilateral pallidal stimulation for disabling dystonia due to Rasmussen's disease.

Carreño M, Martí MJ, Aldecoa I, Painous C, Conde E, Valldeoriola F, Valls-Solé J, Bargalló N, Gil F, Manzanares I, Setoain X, Donaire A, Muñoz E, Roldán P, Boget T, Pintor L, Bailles E, Rumià J.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):108-110. doi: 10.1136/jnnp-2018-318029. Epub 2018 Jul 9.

PMID:
29986904
9.

Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate.

Gidal BE, Jacobson MP, Ben-Menachem E, Carreño M, Blum D, Soares-da-Silva P, Falcão A, Rocha F, Moreira J, Grinnell T, Ludwig E, Fiedler-Kelly J, Passarell J, Sunkaraneni S.

Acta Neurol Scand. 2018 Sep;138(3):203-211. doi: 10.1111/ane.12950. Epub 2018 May 6.

10.

Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.

Andermann E, Biton V, Benbadis SR, Shneker B, Shah AK, Carreño M, Trinka E, Ben-Menachem E, Biraben A, Rocha F, Gama H, Cheng H, Blum D; Study 301, 302 and 304 Investigators.

Epilepsy Behav. 2018 May;82:119-127. doi: 10.1016/j.yebeh.2017.12.017. Epub 2018 Mar 28.

11.

Incidence of seizure exacerbation and seizures reported as adverse events during adjunctive treatment with eslicarbazepine acetate: A pooled analysis of three Phase III controlled trials.

Carreño M, Benbadis S, Rocha F, Blum D, Cheng H; Study 301, 302 and 304 Investigators (Appendix 1).

Epilepsia Open. 2017 Nov 9;2(4):459-466. doi: 10.1002/epi4.12083. eCollection 2017 Dec.

12.

Retrospective study of perampanel efficacy and tolerability in myoclonic seizures.

Gil-López FJ, Montoya J, Falip M, Aparicio J, López-González FJ, Toledano R, Gil-Nagel A, Molins A, García I, Serrano P, Domenech G, Torres F, Donaire A, Carreño M.

Acta Neurol Scand. 2018 Aug;138(2):122-129. doi: 10.1111/ane.12931. Epub 2018 Mar 24.

PMID:
29573400
13.

Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs.

Mintzer S, Wechsler RT, Rogin JB, Gidal BE, Schwab M, Ben-Menachem E, Carreño M, da Silva PS, Moreira J, Li Y, Blum D, Grinnell T.

Epilepsy Res. 2018 Mar;141:83-89. doi: 10.1016/j.eplepsyres.2018.02.001. Epub 2018 Feb 9.

14.

Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.

Rocamora R, Ley M, Molins A, Toledo M, Sansa G, Bertol V, Becerra JL, Carreño M, Mauri JÁ.

Epilepsy Behav. 2018 Feb;79:87-92. doi: 10.1016/j.yebeh.2017.10.032. Epub 2017 Dec 16.

PMID:
29253680
15.

Periodic neck myoclonus during sleep.

Pérez-Carbonell L, Silva C, Gaig C, Carreño M, Santamaria J, Iranzo A.

Sleep Med. 2017 Oct;38:71-72. doi: 10.1016/j.sleep.2017.06.030. Epub 2017 Jul 25. No abstract available.

PMID:
29031759
16.

Outcome of treatment changes in patients with drug-resistant chronic epilepsy: A tertiary center experience.

Martínez-Lizana E, Gil-Lopez F, Donaire A, Aparicio J, Brandt A, Carreño M.

Epilepsy Res. 2017 Oct;136:97-102. doi: 10.1016/j.eplepsyres.2017.07.011. Epub 2017 Jul 29.

PMID:
28810185
17.

Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies.

Falip M, Rodriguez-Bel L, Castañer S, Miro J, Jaraba S, Mora J, Bas J, Carreño M.

Acta Neurol Scand. 2018 Feb;137(2):272-276. doi: 10.1111/ane.12799. Epub 2017 Aug 2.

PMID:
28766694
18.

VNS and pregnancy: A multicentric experience of four cases.

Rodríguez-Osorio X, López-González FJ, Garamendi Í, Rumià J, Matute A, Prieto-González Á, Carreño M.

Acta Neurol Scand. 2017 Oct;136(4):372-374. doi: 10.1111/ane.12780. Epub 2017 May 31.

PMID:
28560798
19.

Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies.

Carreño M, Bien CG, Asadi-Pooya AA, Sperling M, Marusic P, Elisak M, Pimentel J, Wehner T, Mohanraj R, Uranga J, Gómez-Ibáñez A, Villanueva V, Gil F, Donaire A, Bargalló N, Rumià J, Roldán P, Setoain X, Pintor L, Boget T, Bailles E, Falip M, Aparicio J, Dalmau J, Graus F.

Epilepsy Res. 2017 Jan;129:101-105. doi: 10.1016/j.eplepsyres.2016.12.010. Epub 2016 Dec 15.

20.

Erratum to "Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study" [Epilepsy Res. 126 (2016) 201-210].

Villanueva V, Garcés M, López-González FJ, Rodriguez-Osorio X, Toledo M, Salas-Puig J, González-Cuevas M, Campos D, Serratosa JM, González-Giráldez B, Mauri JA, Camacho JL, Suller A, Carreño M, Gómez JB, Montoya J, Rodríguez-Uranga J, Saiz-Diaz R, González-de la Aleja J, Castillo A, López-Trigo J, Poza JJ, Flores J, Querol R, Ojeda J, Giner P, Molins A, Esteve P, Baigesr JJ.

Epilepsy Res. 2017 Jan;129:174-175. doi: 10.1016/j.eplepsyres.2016.12.005. Epub 2016 Dec 22. No abstract available.

PMID:
28017504

Supplemental Content

Loading ...
Support Center